Prednisolone pharmacokinetics in dogs with protein-losing enteropathy.

Background: It is unknown if glucocorticoid malabsorption contributes to the approximate 50% treatment failure rate in dogs with protein-losing enteropathy (PLE).

Objective: To compare pharmacokinetics (PK) of orally administered prednisolone in dogs with PLE vs healthy controls.

Animals: Fourteen dogs with well-characterized PLE and 7 control dogs.

Altered carnitine transporter genes (, , ) expression pattern among lung cancer patients.

Background: Despite the decrease of morbidity rate of non-small cell lung cancer (NSCLC) in recent years, it is still a cancer with poor prognosis. Lung cancers (LCs) are usually diagnosed at a late stage of the disease due to non-specific clinical symptoms. Proper regulation of carnitine levels is important in the context of development and increased risk of cancer cells proliferation.

Two-Dimensional Plasma Soft X-ray Radiation Imaging System: Optimization of Amplification Stage Based on Gas Electron Multiplier Technology.

The objective of the proposed research is to develop plasma soft X-ray (SXR) radiation imaging that includes spectral information in addition to standard SXR tomography for the purpose of studying, for example, tungsten transport and its interplay with magnetohydrodynamics (MHD) in tokamak plasmas in an ITER-relevant approach. The SXR radiation provides valuable information about both aspects, particularly when measured with high spatial and temporal resolution and when tomographic reconstructions are performed. The spectral data will facilitate the tracking of both light and high-Z impurities.

Mitochondrial Dynamics in Non-Small Cell Lung Cancer.

In lung cancer patients, two complementary abnormalities were found that can cause disruption of the mitochondrial network: increased fusion and impaired fission, manifested by reduced levels of FIS1, a mitochondrial division regulator, and increased expression of MFN1, a mitochondrial fusion mediator. Immunoexpression studies of MFN1 and FIS1 proteins were performed in serum samples obtained from 47 patients with non-small cell lung cancer (NSCLC) and 21 controls. In the NSCLC patients, the immunoexpression of the MFN1 protein was significantly higher, and the FIS1 protein level was significantly lower than in the control group ( < 0.